In Canada, the patent for some semaglutide drugs has expired, paving the way for the country to become the first to offer ...

Dublin, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The "Canada Pharmaceutical Market Report by ATC / Therapeutic Class, Drug Type, Distribution Channel, Region, and Company Analysis, 2025-2033" report has been ...

From established players to up-and-coming firms, Canada's pharmaceutical landscape is diverse and dynamic. Canadian drug ...

Health Canada is currently considering nine submissions from other drug companies to make generic semaglutide.

TORONTO--(BUSINESS WIRE)--Today, Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of ...

RALEIGH, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today ...

ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

--DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare, neurodevelopmental disorder SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...

ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows neffy's ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLO™ (plozasiran), a small interfering RNA (siRNA) medicine, ...

Aurobindo Pharma said its subsidiary CuraTeQ Biologics has received a Notice of Compliance from Health Canada for its ...

Canada has a one year grace period for public disclosures made by the applicant. Specific to pharma, Canada shares with the United States a generic drug regulatory regime which links patents listed on ...